help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arsenis, G.
Right arrow Articles by Livingston, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arsenis, G.
Right arrow Articles by Livingston, J. N.

Endocrinology, Vol 119, 50-57, Copyright © 1986 by Endocrine Society


ARTICLES

Isoproterenol reduces insulin stimulation of hexose uptake by rat adipocytes via a postinsulin binding alteration

G Arsenis and JN Livingston

The present studies have investigated the acute changes previously reported in insulin binding and insulin action that occur in fat cells after a 30-min treatment with isoproterenol. We find that the marked reduction in high affinity insulin binding can be explained by a drop in the pH of the incubation medium from 7.4 to 6.9, a change associated with the accelerated production of FFA. The alteration in insulin binding may explain the rightward shift in the insulin dose response for the stimulation of glucose transport. When the incubation medium is modified to prevent the pH change, isoproterenol stimulation fails to reduce insulin binding. In addition, the tyrosine kinase activity of the insulin receptor isolated from isoproterenol-treated cells is not altered, at least as measured by the phosphorylation of tyrosine residues on the artificial substrate, Glu80Tyr20. There are, however, changes produced in the insulin stimulation of 2-deoxy-D-glucose uptake. The response of the cells to a maximum effective concentration of insulin is reduced 35% by a 30-min treatment with 0.1 microM isoproterenol. This change occurs in parallel with a moderate rightward shift in the insulin dose-response curve. Thus, isoproterenol treatment rapidly alters the ability of the adipocyte hexose transport system to respond to insulin, but the responsible alteration(s) is located beyond the insulin-binding site and possibly beyond the insulin receptor itself.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society